It has been reported that aberrant cyclin D3 expression was found in various cancers, including leukemia, hepatocellular carcinoma, gliomas, bladder carcinoma, prostate cancer, osteosarcoma and breast cancer [85, 86]. Here, CCND3 is linked to hepatocellular carcinoma.